This section is
Author of the article:
GlobeNewswire
Published Jun 02, 2024 • 3 minute read
![KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (3) KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (3)](https://i0.wp.com/smartcdn.gprod.postmedia.digital/financialpost/wp-content/uploads/2024/06/kfshrc-successfully-treats-severe-case-of-xanthoma-after-26-.jpeg?quality=90&strip=all&w=288&h=216&sig=3ahIGM9BmVuiZCBiTErQBQ)
![KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (4) KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (4)](https://i0.wp.com/ml.globenewswire.com/Resource/Download/7a207d87-92db-4ac7-97f7-98df9d2c7ee0/kfshrc-jeddah.jpg?quality=90&strip=all&w=288&sig=Z_Ohlv27KY00yWHydv4_2Q)
We apologize, but this video has failed to load.
Try refreshing your browser, or
tap here to see other videos from our team.
KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering Back to video
JEDDAH, Saudi Arabia, June 02, 2024 (GLOBE NEWSWIRE) — In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment of a modified plasma exchange protocol. This milestone underscores KFSHRC’s position as a trailblazer in healthcare innovation and patient care, particularly in addressing complex cases.
Advertisem*nt 2
Story continues below
This advertisem*nt has not loaded yet, but your article continues below.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, Victoria Wells and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, Victoria Wells and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
Sign In or Create an Account
or
View more offers
Article content
Xanthoma, characterized by the accumulation of triglyceride-filled deposits beneath the skin, signals not just dermatological but deeper systemic health challenges. The condition’s recurrent nature and the difficulty in finding lasting solutions have made it a focal point for KFSHRC’s innovative treatment protocols. A notable case involved a 58-year-old patient who, after a 26-year battle with Xanthoma and seeking treatments globally from renowned healthcare institutions, found hope in KFSHRC’s bespoke treatment strategy.
Central to KFSHRC’s successful intervention was implementing a modified plasma exchange technique, tailored specifically to address the unique complexities of such severe Xanthoma, particularly tackling the patient’s extreme triglyceride levels and halting the disease’s progression. The integration of advanced apheresis technology and state-of-the-art imaging and diagnostic tools enabled the team to understand the disease and its impact thoroughly, laying the foundation for an effective treatment plan. This effort was the culmination of a multidisciplinary collaboration among nutritionists, endocrinologists, and immunohematologists, who united to formulate a holistic treatment strategy. This therapeutic strategy is now published in JCEM, which is considered the world’s leading peer-reviewed journal for endocrine clinical research and clinical practice. The treatment protocol combined dual action to mitigate the visible symptoms and address the root causes of Xanthoma.
Top Stories
Get the latest headlines, breaking news and columns.
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Advertisem*nt 3
Story continues below
This advertisem*nt has not loaded yet, but your article continues below.
Article content
Characterized by its precision and effectiveness, this technique marks a significant advancement in treatment modalities, introducing innovative ways to tackle conditions previously deemed untreatable, and thereby setting new standards in patient-centred care.
This comprehensive approach, which requires advanced expertise and cutting-edge skills in eliminating harmful biological substances via extracorporeal circulation, not only showcased the hospital’s adaptability and proficiency but also its commitment to pushing the boundaries of medical care.
“In addressing the patient’s challenging case of xanthoma, where multiple treatment modalities previously failed, we combined our clinical insights with an innovative application of modified plasma exchange, emphasizing our commitment to personalized healthcare,” says Professor Ashraf Dada, Chairman of the Department of Pathology and Laboratory Medicine at KFSHRC in Jeddah, who led the medical care team. “This method, though less common, was chosen for its potential to precisely target the patient’s specific condition.”
Advertisem*nt 4
Story continues below
This advertisem*nt has not loaded yet, but your article continues below.
Article content
This landmark achievement not only sets new benchmarks in medical care for challenging conditions like Xanthoma but also reflects the potential of innovative treatment protocols to significantly improve patient quality of life and contribute to the scientific community. As KFSHRC continues to pioneer medical breakthroughs, its stature as a global healthcare leader becomes increasingly evident. The institution’s proactive engagement in medical research and innovation, alongside its dedication to sharing insights and fostering international collaborations, introduces new paradigms in the comprehension and treatment of complex diseases.
Further advancing these efforts, KFSHRC’s breakthrough not only provides hope for those with similar conditions but also places the institution at the forefront of medical innovation, highlighting its commitment to research, clinical excellence, and patient experience.
KFSHRC has retained its status as the leading institution in the Middle East and Africa for the second year running and ranks 20th globally among the top 250 academic medical centers worldwide. It is also recognized as the most valuable healthcare brand in the Kingdom and the Middle East in 2024, according to Brand Finance. Additionally, Newsweek Magazine has ranked it among the top 250 hospitals globally.
For further information, please contact:
Mr. Essam AlZahrani, Acting Head of Media Affairs, 0555254429
Mr. Abdullah Alown, Media Coordination Officer, 0556294232
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7a207d87-92db-4ac7-97f7-98df9d2c7ee0
![KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (9) KFSHRC Successfully Treats Severe Case of 'Xanthoma' After 26 Years of Suffering (9)](https://i0.wp.com/ml.globenewswire.com/media/Yzk5ZWUyYWEtODA4OC00NTE4LTkyZjUtOTY1YzAwOTI0NWQxLTUwMDExOTYyNQ==/tiny/King-Faisal-Specialist-Hospita.png)
Article content
Comments
You must be logged in to join the discussion or read more comments.
Create an AccountSign in
Join the Conversation
Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.
Trending
- Bank of Canada's Tiff Macklem signals more rate cuts possible after historic shift
- What the Bank of Canada rate cut means for mortgages, loans and investments
- More and more people are discovering they are 'rich' in the eyes of Liberals
- Bank of Canada seen cutting interest rates three more times this year
- Posthaste: Hoping Bank of Canada rate cut will spark housing boom? — don't hold your breath
This Week in Flyers